UK markets closed

Cigna Corporation (CI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
254.77-2.11 (-0.82%)
As of 12:14PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 81.72B
Enterprise value 110.48B
Trailing P/E 15.99
Forward P/E 11.74
PEG ratio (5-yr expected) 1.06
Price/sales (ttm)0.49
Price/book (mrq)1.77
Enterprise value/revenue 0.62
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-2.04%
S&P500 52-week change 3-6.14%
52-week high 3271.71
52-week low 3191.74
50-day moving average 3250.66
200-day moving average 3225.80

Share statistics

Avg vol (3-month) 31.59M
Avg vol (10-day) 31.79M
Shares outstanding 5317.27M
Implied shares outstanding 6N/A
Float 8315.92M
% held by insiders 11.52%
% held by institutions 190.29%
Shares short (28 Apr 2022) 43.21M
Short ratio (28 Apr 2022) 42.42
Short % of float (28 Apr 2022) 41.01%
Short % of shares outstanding (28 Apr 2022) 41.01%
Shares short (prior month 30 Mar 2022) 43.53M

Dividends & splits

Forward annual dividend rate 44.48
Forward annual dividend yield 41.74%
Trailing annual dividend rate 34.12
Trailing annual dividend yield 31.60%
5-year average dividend yield 40.30
Payout ratio 425.57%
Dividend date 322 Jun 2022
Ex-dividend date 406 Jun 2022
Last split factor 23:1
Last split date 304 Jun 2007

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 3.04%
Operating margin (ttm)4.69%

Management effectiveness

Return on assets (ttm)3.40%
Return on equity (ttm)11.53%

Income statement

Revenue (ttm)176.99B
Revenue per share (ttm)535.48
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)23.16B
EBITDA 10.1B
Net income avi to common (ttm)5.39B
Diluted EPS (ttm)16.16
Quarterly earnings growth (yoy)1.90%

Balance sheet

Total cash (mrq)5.15B
Total cash per share (mrq)16.25
Total debt (mrq)33.75B
Total debt/equity (mrq)73.10
Current ratio (mrq)0.81
Book value per share (mrq)144.61

Cash flow statement

Operating cash flow (ttm)8.13B
Levered free cash flow (ttm)2.81B